ChemiCare | It's a rare thing to care

🌟 Exciting times at the INNOVIT - Italian Innovation and Culture Hub acceleration program for startups and scale-ups in Life Sciences & Digital Health in San Francisco! Attending this program has been an incredible journey, strengthening the bond between the Italian ecosystem and Silicon Valley, the global heart of innovation. 🚀 The connections we've established with local investors and leading pharma companies have been invaluable, propelling our company forward. 🤝 The collaborative spirit and shared experiences have created a supportive community that will continue to thrive beyond this program. Thanks to the entire INNOVIT team for organizing such experience. #LifeSciences #Innovation #SiliconValley #Startups #ScaleUps #Networking #SanFrancisco #ItalianEcosystem

ChemiCare desk is ready in INNOVIT - Italian Innovation and Culture Hub, San Francisco. Beatrice Riva Luigi Azzarone

🌎 Few days missing for our participation in the upcoming acceleration program starting on June 10th in San Francisco, organized by INNOVIT - Italian Innovation and Culture Hub. 🚀 This is a fantastic opportunity for us to promote growth and collaboration. We'll be engaging in intensive workshops, benefiting from tailored mentoring, and taking advantage of networking opportunities right in the heart of Silicon Valley. Stay tuned for updates! 🚀 #LifeSciences #Innovation #Growth #Collaboration #Workshops #Mentoring #Networking #SiliconValley #DemoDay #Healthcare #Startups

👇👇

📆 Today, on Rare Disease Day, we stand united in raising awareness for over 300 million individuals worldwide who bravely face the challenges of living with rare diseases. In ChemiCare, we are committed to making a meaningful impact on the lives of these resilient individuals. 💙 Our daily mission revolves around improving the quality of life for those battling rare diseases. Through innovation, research, and dedicated efforts, we aim to provide support, resources, and hope to those who need it most. #rarediseaseday

📣 ChemiCare and Bridge4Pharma are joining forces into a partnership to push forward the development of pipeline initiatives. 🤝 Together with this alliance, Bridge4Pharma S.r.l., decided to invest in ChemiCare S.r.l.   🔬 Bridge4Pharma, a company focused on supporting research and development projects and activities based on diagnostic, therapeutic and medical device technologies, will strategically support ChemiCare operations in preclinical and clinical drug development.   “Thanks to the collaboration with Bridge4Pharma and it’s consolidated experience in Research and Development, ChemiCare has the objective to rapidly progress its lead molecule CIC-39 to clinical stage. CIC-39 is a small molecule selectively targeting a key mechanism involved in severe and lethal forms of muscular degeneration like Duchenne Muscular Distrophy (DMD) and Tubular Aggregated Myopathies (TAM) for which no effective treatments exist to date. We are confident that this partnership will bring a concrete and solid contribution to our mission.” Beatrice Riva, Co-Founder & CEO, ChemiCare S.r.l.   “The collaboration between ChemiCare and Bridge4Pharma will leverage on the respective capabilities and experience to progress an innovative approach that can potentially address unmet medical needs in severe and lethal muscle disorders. We look forward to working jointly to bring this and future programs into the clinics. ”  Maurizio F. Mariani, President & CEO, Bridge4Pharma S.r.l.

🌟 Yesterday our research assistant Luigi Azzarone took the stage as one of the speakers at MIND Education, a program organized by the MIND Milano Innovation District's main partners. The focus was on engaging and motivating the district's future players: the students. 🧭 The primary goal of this meeting was to guide students in their future choices, providing them with a unique journey into the world of research and innovation, with a particular emphasis on pharmaceutical and biomedical fields. 🎙️ The audience, consisting of students from scientific high schools with a biomedical orientation and ITS Mechatronics, had the opportunity to hear valuable testimonies from the realities that animate MIND such as Bio4Dreams. It was a fantastic opportunity to inspire and empower the next generation of innovators.

🚀 Yesterday our Research Assistant Luigi Azzarone was among the panelists at the “Strengthening life-sciences innovation across Europe” conference organized by the European Innovation Network (EU-IN) and the Health Products Regulatory Authority (HPRA). 🌐 At this dynamic event, developers and regulators joined forces, engaging in insightful dialogue toward the possibilities to catalyze the innovation into impactful pharma and med-tech products. Luigi actively participated in knowledge exchange sessions, delving into Bio4Dreams structure, collaboration, developments, and future challenges. Their commitment to staying at the forefront of regulatory readiness was evident, as they explored expertise and regulatory standards crucial for success in this rapidly evolving landscape, helping ChemiCare to achieve important regulatory milestones.

🌐 Si è svolta oggi a Dublino “Strengthening life-sciences innovation across Europe”: una conferenza – organizzata dall’European Innovation Network (EU-IN) e ospitata dall’Health Products Regulatory Authority (HPRA) – che ha coinvolto incubatori e TTO provenienti da tutta Europa con l’obiettivo di supportare e favorire nuovi sviluppi tecnologici innovativi nei campi della medicina e della biofarmaceutica. 🔎 Sono stati trattati diversi temi – come l’esigenza di rafforzare gli ecosistemi europei dell’innovazione o la necessità di potenziare il dialogo tra i diversi stakeholder – e, in quest’ottica, le realtà coinvolte hanno raccontato le proprie strategie per facilitare la transizione tecnologica delle idee accademiche. 🎙️ Bio4Dreams ha preso parte a questa conferenza con Luigi Azzarone, Startup Analyst, il quale non solo ha presentato l’incubatore, con un focus particolare sull’ecosistema dell’innovazione che sta sviluppando nell’Est Europa, ma ha anche portato un esempio virtuoso di spinoff universitario cresciuto fino a diventare una PMI solida, strutturata e riconosciuta dall’Ente Regolatorio europeo European Medicines Agency: ChemiCare | It's a rare thing to care.